静脉点滴素高捷疗对脑梗塞急性期的临床疗效观察  

CLINICAL OBSERVATION ON THE EFFlCACY OF IVT SOLCOSERYL IN COMPARISON WITH CONTROL IN ACUTE CEREBRAL INFARCTION

作　　者：魏镜[1] 彭斌[1] 李欢[1] 李舜伟[1] 孟家眉[1] 田明婷 余华峰[1] 项曼君[1] 

机构地区：[1]北京协和医院神经科,北京宣武医院神经科,北京同仁医院神经科,首都医学院

出　　处：《中国新药杂志》1995年第6期31-34,共4页Chinese Journal of New Drugs

摘　　要：总结了应用基础治疗（复方丹参）辅以素高捷疗对脑梗塞急性期病人的临床疗效，并与基础治疗进行对照。共观察了６２例病人，治疗组和对照组各３１例。观察结果显示，无论是对自觉症状还是对临床神经功能缺损程度的改善，治疗组均优于对照组。且治疗时间长者（２０ｄ）疗效优于治疗时间短者（如１０ｄ）。素高捷疗的安全性良好，与复方丹参相似。是值得应用和推广的一种脑细胞代谢赋活剂。The study was conducted in 62 patients with acute cerebral infarc-tion。All of them were treated with IV red-sage-mot complex and half of them also treated with IVT Solcoseryl in addition to red-sage-root complex。The results showed that clinical symptoms and degree of neurological deficiency in Solcoseryl treated group were significantly improved by statistics.The efficacy in patients with treatment dura- tion of 20 days is better than those of 10 days。

关 键 词：素高捷疗 脑梗塞 临床疗效 

分 类 号：R743.330.5[医药卫生—神经病学与精神病学] R969.4[医药卫生—临床医学]